Here's the live share price of Dishman Carbogen Amcis along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Dishman Carbogen Amcis has gained 11.94% CAGR. Over the past year, the corresponding return has been 48.73%.
Dishman Carbogen Amcis’s current P/E of 43.25x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Dishman Carbogen Amcis | 7.60 | 9.21 | 14.47 | 32.52 | 48.73 | 41.70 | 11.94 |
Sun Pharmaceutical Industries | 2.44 | 1.01 | 0.08 | -5.70 | -10.03 | 23.54 | 25.80 |
Divi's Laboratories | 1.48 | -1.04 | -6.66 | 5.61 | 11.59 | 19.02 | 12.76 |
Cipla | 1.05 | 0.82 | 5.27 | 4.55 | -4.52 | 15.08 | 14.35 |
Torrent Pharmaceuticals | -0.61 | -2.60 | 10.27 | 13.47 | 5.88 | 33.98 | 19.88 |
Dr. Reddy's Laboratories | 1.47 | 4.64 | 0.74 | 13.55 | 0.67 | 17.28 | 4.42 |
Mankind Pharma | 1.47 | 6.68 | 11.93 | 22.76 | 9.94 | 22.77 | 13.10 |
Zydus Lifesciences | 0.53 | 6.33 | 9.52 | 16.16 | -2.81 | 42.87 | 20.72 |
Lupin | 3.09 | 4.09 | 4.93 | 0.72 | -7.84 | 47.29 | 13.56 |
Abbott India | 0.01 | -5.05 | -1.67 | 3.97 | 11.46 | 21.23 | 13.41 |
Aurobindo Pharma | 1.70 | 3.53 | 1.94 | -0.76 | -26.66 | 29.49 | 6.38 |
Alkem Laboratories | 1.53 | 2.45 | 14.06 | 13.83 | -10.04 | 19.08 | 13.91 |
Glenmark Pharmaceuticals | -0.70 | 6.98 | 27.23 | 44.88 | 28.39 | 78.62 | 32.94 |
Laurus Labs | 3.14 | 6.66 | 39.13 | 57.29 | 90.35 | 22.06 | 25.31 |
Biocon | 1.24 | 1.14 | 7.66 | 9.58 | 1.29 | 8.29 | -4.09 |
Anthem Biosciences | 4.22 | 6.77 | 17.06 | 17.06 | 17.06 | 5.39 | 3.20 |
GlaxoSmithKline Pharmaceuticals | -3.51 | -0.94 | -15.87 | -1.02 | -1.14 | 25.11 | 10.22 |
Cohance Lifesciences | -8.65 | 1.11 | -9.70 | -19.77 | -20.60 | 25.49 | 18.61 |
Ipca Laboratories | 2.50 | -2.87 | -1.28 | -0.09 | -6.88 | 16.19 | 4.36 |
Gland Pharma | 2.66 | 2.34 | 16.40 | 27.61 | 9.52 | -3.50 | 2.08 |
Over the last one year, Dishman Carbogen Amcis has gained 48.73% compared to peers like Sun Pharmaceutical Industries (-10.03%), Divi's Laboratories (11.59%), Cipla (-4.52%). From a 5 year perspective, Dishman Carbogen Amcis has underperformed peers relative to Sun Pharmaceutical Industries (25.80%) and Divi's Laboratories (12.76%).
Day | SMA | EMA |
---|---|---|
5 | 270.36 | 268.16 |
10 | 271.02 | 268.96 |
20 | 269.68 | 267.22 |
50 | 259.57 | 260.87 |
100 | 249.14 | 252.32 |
200 | 243.78 | 239.89 |
In the latest quarter, Dishman Carbogen Amcis remained same as its previous close in promoter holding, while DII stake increased to 1.27%, FII holding rose to 9.94%, and public shareholding moved down to 29.48% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
HSBC Flexi Cap Fund | 14,76,000 | 0.78 | 39.06 |
L&T Flexicap Fund - Regular Plan | 23,77,050 | 0.81 | 23.47 |
Motilal Oswal BSE Healthcare ETF | 1,541 | 0.13 | 0.04 |
Date Time | Announcement |
---|---|
Sep 17, 2025, 3:10 PM IST | Dishman Carbogen Amc - Announcement under Regulation 30 (LODR)-Investor Presentation |
Sep 05, 2025, 11:41 PM IST | Dishman Carbogen Amc - ANNUAL GENERAL MEETING AND E-VOTING NOTICE - NEWS PAPER ADVERTISEMENT |
Sep 04, 2025, 1:14 AM IST | Dishman Carbogen Amc - SUBMISSION OF NOTICE OF 18TH ANNUAL GENERAL MEETING ALONGWITH ANNUAL REPORT FOR THE FINANCIAL YEAR 202 |
Sep 04, 2025, 1:10 AM IST | Dishman Carbogen Amc - Business Responsibility and Sustainability Reporting (BRSR) |
Sep 04, 2025, 1:05 AM IST | Dishman Carbogen Amc - Reg. 34 (1) Annual Report. |
Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 399.84 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dishman Carbogen Amcis is ₹287.50 as on Sep 18, 2025.
The Dishman Carbogen Amcis is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Dishman Carbogen Amcis is ₹4,507.51 Cr as on Sep 18, 2025.
Today’s highest and lowest price of Dishman Carbogen Amcis are ₹288.85 and ₹276.30.
The 52-week high/low is the highest and lowest price at which Dishman Carbogen Amcis stock has traded in the past 52-week or nearly a year. The 52-week high of Dishman Carbogen Amcis is ₹307.80 and 52-week low of Dishman Carbogen Amcis is ₹161.35 as on Sep 18, 2025.
The Dishman Carbogen Amcis has shown returns of 3.62% over the past day, 9.21% for the past month, 14.47% over 3 months, 48.73% over 1 year, 41.7% across 3 years, and 11.94% over 5 years.
P/E ratio of and PB ratio of Dishman Carbogen Amcis are 43.25 and 0.79 on Sep 18, 2025. While the company gives a dividend yield of 0.00 per annum.